Siren, L.L.C. Dyne Therapeutics, Inc. Call Options Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
201Shares Held
103MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$274 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$252 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$234 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$233 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$233 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.77B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...